These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 3535934
1. [Cancer of the prostate: current status of chemotherapy]. Bollak C, Bergerat JP, Jacquemin D. Bull Cancer; 1986; 73(1):61-4. PubMed ID: 3535934 [Abstract] [Full Text] [Related]
2. The role of chemotherapy in prostate cancer. Minireview. Odrázka K, Vanásek J, Vaculíková M, Stejskal J, Filip S. Neoplasma; 2000; 47(4):197-203. PubMed ID: 11043822 [Abstract] [Full Text] [Related]
4. The present role of estramustine phosphate in advanced prostate cancer. Van Poppel H, Baert L. Prog Clin Biol Res; 1991; 370():323-41. PubMed ID: 1924466 [Abstract] [Full Text] [Related]
13. Immunotherapy for prostate cancer - recent progress in clinical trials. Kipp RT, McNeel DG. Clin Adv Hematol Oncol; 2007 Jun; 5(6):465-74, 477-9. PubMed ID: 17679921 [Abstract] [Full Text] [Related]
14. Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus long-term androgen suppression plus radiotherapy alone for high-risk prostate cancer: preliminary toxicity analysis of RTOG 99-02. Rosenthal SA, Bae K, Pienta KJ, Sobczak ML, Asbell SO, Rajan R, Kerlin KJ, Michalski JM, Sandler HM, Radiation Therapy Oncology Group Trial 9902. Int J Radiat Oncol Biol Phys; 2009 Mar 01; 73(3):672-8. PubMed ID: 18990504 [Abstract] [Full Text] [Related]
16. Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate metastatic prostate cancer. Galsky MD, Small EJ, Oh WK, Chen I, Smith DC, Colevas AD, Martone L, Curley T, Delacruz A, Scher HI, Kelly WK. J Clin Oncol; 2005 Mar 01; 23(7):1439-46. PubMed ID: 15735119 [Abstract] [Full Text] [Related]
17. Management of hormone refractory prostate cancer: current standards and future prospects. Oh WK, Kantoff PW. J Urol; 1998 Oct 01; 160(4):1220-9. PubMed ID: 9751323 [Abstract] [Full Text] [Related]
18. Is there a role for platinum chemotherapy in the treatment of patients with hormone-refractory prostate cancer? Oh WK, Tay MH, Huang J. Cancer; 2007 Feb 01; 109(3):477-86. PubMed ID: 17186531 [Abstract] [Full Text] [Related]